Premium
Is entecavir ideal for the treatment of lamivudine‐refractory chronic hepatitis B?
Author(s) -
Su ChienWei,
Wu JawChing,
Lee ShouDong
Publication year - 2008
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.22520
Subject(s) - lamivudine , entecavir , adefovir , medicine , nucleoside analogue , refractory (planetary science) , virology , drug resistance , hepatitis b , gastroenterology , hepatitis b virus , nucleoside , virus , biology , astrobiology , biochemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom